Learn about single-hand placement with a built-in loading tip

GET STARTED

About Paragard®

The IUS that won’t interfere with your patient
or their future choices.

Long-Lasting Protection With Continuous Efficacy That Lasts up to 10 Years1

Paragard is one of the most effective birth control options available*†

Review Efficacy of
Birth Control Options

#1 Hormone-Free IUS

Talk to your patients about hormone-free options

Did you know?

  • 71% of women who use or are planning to use birth control have concerns about hormones3‡
  • 1 in 4 Paragard users wants a hormone-free option because they want to continue to have a monthly period4

Download Paragard Counseling Sheet

Immediately Reversible Whenever They Decide1

Paragard can be removed at year 1, year 10, or anytime in between, and patients can start trying to conceive the same day it’s removed§

Now With Improved Placement Process

Place Paragard efficiently with a single-hand inserter and built-in loading tip1

Watch the Training Video

Allows Patients to Keep Their Normal Cycle1

In a survey, more women reported experiencing no significant changes in their natural menstrual cycle than those who did.4¶

Learn More

High Patient Satisfaction

93% of women using Paragard have reported satisfaction at 3 and 6 months post-placement4II

See Continuation Rates of
Paragard and Other LARCs

How Does Paragard
Work?

Paragard uses 1 simple active ingredient—copper—to prevent pregnancy. Copper enhances contraceptive efficacy by
interfering with sperm transport and fertilization, possibly
preventing implantation.1†

Learn More

LARC=Long-Acting Reversible Contraceptive.

*Excluding sterilization.

†Paragard is over 99% effective.

‡Based on an August 2021 web-based survey of women aged 18-45 (n=1,063) who currently use birth control or plan to use birth control in the next 12 months.

§Paragard must be removed by a healthcare provider.

Based on an April 2023 web-based survey of women aged 18-50 (n=1,004) who currently use Paragard birth control and have for at least 1 year, 48% reported no significant changes, 46% reported changes, and 6% did not remember. At first, periods may become heavier and longer with spotting in between.

||According to a study of 5,011 LARC users (826 using Paragard), who were asked to report changes in bleeding and cramping since their LARC was placed.

INDICATIONS AND USAGE

Paragard is a copper-containing intrauterine system (IUS) indicated for prevention of pregnancy in females of reproductive potential for up to 10 years.

IMPORTANT SAFETY INFORMATION

CONTRAINDICATIONS

  • The use of Paragard is contraindicated when one or more of the following conditions exist:
    • Pregnancy or suspicion of pregnancy, abnormalities of the uterus resulting in distortion of the uterine cavity, acute pelvic inflammatory disease (PID), postpartum or postabortal endometritis in the past 3 months, known or suspected uterine or cervical malignancy, uterine bleeding of unknown etiology, untreated acute cervicitis or vaginitis or other lower genital tract infection, conditions associated with increased susceptibility to pelvic infections, Wilson’s disease, a previously placed IUS that has not been removed, hypersensitivity to any component of Paragard including to copper or any of the trace elements present in the copper component of Paragard.

INDICATIONS AND USAGE

Paragard is a copper-containing intrauterine system (IUS) indicated for prevention of pregnancy in females of reproductive potential for up to 10 years.

IMPORTANT SAFETY INFORMATION

CONTRAINDICATIONS

  • The use of Paragard is contraindicated when one or more of the following conditions exist:
    • Pregnancy or suspicion of pregnancy, abnormalities of the uterus resulting in distortion of the uterine cavity, acute pelvic inflammatory disease (PID), postpartum or postabortal endometritis in the past 3 months, known or suspected uterine or cervical malignancy, uterine bleeding of unknown etiology, untreated acute cervicitis or vaginitis or other lower genital tract infection, conditions associated with increased susceptibility to pelvic infections, Wilson’s disease, a previously placed IUS that has not been removed, hypersensitivity to any component of Paragard including to copper or any of the trace elements present in the copper component of Paragard.

WARNINGS AND PRECAUTIONS

  • Ectopic Pregnancy: Evaluate for possible ectopic pregnancy in any female who becomes pregnant while using Paragard.
  • Intrauterine Pregnancy: Failure to remove Paragard increases the risk of miscarriage, sepsis, premature labor, and premature delivery.
  • Sepsis: Severe infection or sepsis, including Group A Streptococcal Sepsis (GAS), have been reported following insertion of IUSs, including Paragard.
  • Pelvic Inflammatory Disease and Endometritis: Remove Paragard in cases of recurrent PID or endometritis, or if an acute pelvic infection is severe or does not respond to treatment.
  • Embedment: Partial penetration or embedment of Paragard in the myometrium can make removal difficult; surgical removal may be necessary. Breakage of an embedded Paragard during non-surgical removal has been reported.
  • Perforation: Partial or total perforation of the uterine wall or cervix may reduce contraceptive efficacy and result in pregnancy. Delayed detection or removal of Paragard may result in migration outside the uterine cavity, adhesions, peritonitis, intestinal penetration, intestinal obstruction, abscesses and/or damage to adjacent organs. Increased risk when the uterus is fixed, retroverted or not completely involuted during the postpartum period. If perforation does occur, locate and remove Paragard promptly.
  • Expulsion: Partial or complete expulsion of Paragard has been reported, resulting in the loss of contraceptive protection. The risk of expulsion may be increased when the uterus is not completely involuted at the time of insertion. Remove a partially expelled Paragard.
  • Wilson’s Disease: Paragard may exacerbate Wilson’s disease.
  • Bleeding Pattern Alterations: Paragard can alter the bleeding pattern and result in heavier and longer menstrual cycles with intermenstrual spotting.
  • Magnetic Resonance Imaging (MRI) Safety Information: Non-clinical testing has demonstrated that Paragard is MR Conditional.
  • Medical Diathermy: Avoid using high medical RF transmitter devices in females with Paragard.

ADVERSE REACTIONS

  • Adverse reactions reported in clinical trials include anemia, backache, dysmenorrhea, dyspareunia, expulsion (complete or partial), prolonged menstrual flow, menstrual spotting, pain and cramping, and vaginitis.

INDICATIONS AND USAGE

Paragard is a copper-containing intrauterine system (IUS) indicated for prevention of pregnancy in females of reproductive potential for up to 10 years.

Please see full Prescribing Information for Paragard and Paragard | Single-Hand Inserter.

References:

1. Paragard® Package Insert, Trumbull, CT: CooperSurgical, Inc. 2024.

2. Data on File: Paragard Patient View Ad Brand Tracking - August 2021.

3. Data on File: Paragard User Survey Report - May 2023.

4. Diedrich JT, Desai S, Zhao Q, et al. Association of short-term bleeding and cramping patterns with long-acting reversible contraceptive method satisfaction. Am J Obstet Gynecol. 2015;212(1):50.e1-50.e8.